Výsledky vyhledávání - "Erica Visintin"

Autor: Panos Kanavos, Anna-Maria Fontrier, Erica Visintin

Publikováno v: PharmacoEconomics - open. 6(3)

Health technology assessment (HTA) systems across countries vary in the way they are set up, according to their role and based on how funding decisions are reached. Our objective was to study the characteristics of these systems and their likely impa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6e7cb4d240376fe8019c6cb19507ecb
https://pubmed.ncbi.nlm.nih.gov/35776409

Zobrazit plný text záznamu

Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study

Autor: John Cairns, Elena Nicod, Laia Maynou, Erica Visintin

Publikováno v: Health Economics, Policy and Law. 15:386-402

Using quantitative and qualitative research designs, respectively, two studies investigated why countries make different health technology assessment (HTA) drug reimbursement recommendations. Building on these, the objective of this study was to (a)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::246e4729cb0ab80fcf72316b27d13230
https://doi.org/10.1017/s1744133119000239

Zobrazit plný text záznamu

Value assessment of disease-modifying therapies for Relapsing-Remitting Multiple Sclerosis: HTA evidence from seven OECD countries

Autor: Panos Kanavos, Erica Visintin, Michela Tinelli

Publikováno v: Health Policy. 123:118-129

This study systematically compares HTA recommendations on a number of disease-modifying therapies for patients with Relapsing-Remitting Multiple Sclerosis. We analysed publicly available HTA reports for nine medicine-indication pairs across seven OEC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5f422f27218ad2998849b610c48e38
https://doi.org/10.1016/j.healthpol.2018.08.019

Zobrazit plný text záznamu

Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries

Autor: Anna-Maria Fontrier, Erica Visintin, Panos Kanavos

Publikováno v: PharmacoEconomics - Open. 6:629-629

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::878e7d129cdd9afa774bc727da48055f
https://doi.org/10.1007/s41669-022-00345-3

Zobrazit plný text záznamu

Using IMPrESS to guide policy change in multiple sclerosis

Autor: Federico Grimaccia, Olina Efthymiadou, Jean Mossman, Panos Kanavos, Erica Visintin, Michela Tinelli

Publikováno v: Multiple Sclerosis Journal. 24:1251-1255

The International MultiPlE Sclerosis Study (IMPrESS) studied the significant impact of multiple sclerosis (MS) on the health and well-being of both people with the disease and their caregivers, along with its broader socioeconomic impact. Results con

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33afecaabed6520a14f1bf2c6a49954c
https://doi.org/10.1177/1352458517737388

Zobrazit plný text záznamu

The Impress (International Multiple Sclerosis) Study; Results On The Socio-Economic Burden, Health Related Quality Of Life And Experience Of Multiple Sclerosis Patients In France

Autor: Michela Tinelli, Panos Kanavos, Olina Efthymiadou, Federico Grimaccia, Jean Mossman, Erica Visintin

Publikováno v: Value in Health. 19:A429-A430

OBJECTIVES: This study aimed to capture the socio-economic costs, Health Related Quality of Life (HRQoL) and experience of Multiple Sclerosis (MS) patients in France. METHODS: An online survey of non-institutionalised MS patients collected data on de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c2b2c0ed32684236d26e49578d464607
https://doi.org/10.1016/j.jval.2016.09.481

Zobrazit plný text záznamu

The economic burden of diabetes in India: a review of the literature

Autor: Charles A K Yesudian, Mari Grepstad, Alessandra Ferrario, Erica Visintin

Publikováno v: Globalization and Health

Background Diabetes and its complications are a major cause of morbidity and mortality in India, and the prevalence of type 2 diabetes is on the rise. This calls for an assessment of the economic burden of the disease. Objective To conduct a critical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfea9c95b55e34d55eafade99cfeea47
http://europepmc.org/articles/PMC4279984

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání